Walleye Capital’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.58M Sell
270,000
-405,800
-60% -$10.8M 0.03% 541
2025
Q4
$16.8M Sell
675,800
-33,500
-5% -$845K 0.05% 370
2025
Q3
$18.1M Sell
709,300
-176,900
-20% -$4.37M 0.07% 289
2025
Q2
$21.5M Buy
886,200
+105,100
+13% +$2.45M 0.08% 209
2025
Q1
$19.8M Sell
781,100
-509,400
-39% -$13.3M 0.09% 210
2024
Q4
$34.2M Sell
1,290,500
-291,000
-18% -$7.89M 0.08% 183
2024
Q3
$45.8M Buy
1,581,500
+234,600
+17% +$6.84M 0.1% 134
2024
Q2
$37.7M Buy
1,346,900
+74,200
+6% +$2.04M 0.07% 173
2024
Q1
$35.3M Buy
1,272,700
+13,000
+1% +$361K 0.06% 214
2023
Q4
$36.3M Buy
1,259,700
+328,200
+35% +$9.92M 0.08% 160
2023
Q3
$30.9M Buy
931,500
+203,300
+28% +$7.19M 0.08% 139
2023
Q2
$26.7M Buy
728,200
+649,700
+828% +$25.3M 0.1% 108
2023
Q1
$3.2M Buy
78,500
+63,500
+423% +$2.74M 0.05% 476
2022
Q4
$769K Sell
15,000
-17,500
-54% -$839K 0.01% 1162
2022
Q3
$1.42M Buy
+32,500
New +$1.58M 0.03% 738
2019
Q4
Sell
-36,152
Closed -$1.23M 2152
2019
Q3
$1.23M Buy
36,152
+26,244
+265% +$954K 0.07% 371
2019
Q2
$407K Buy
9,908
+9,381
+1,780% +$373K 0.04% 588
2019
Q1
$21K Buy
+527
New +$21.1K ﹤0.01% 1339
2018
Q3
$176K Buy
+4,216
New +$162K 0.08% 232

Other funds holding PFE

Walleye Capital's PFE Position: Q1 2026 in Review

Walleye Capital increased its Pfizer (PFE) stake by 126% in Q1 2026, buying an estimated $15.9M and bringing the position to 1,070,486 shares worth $30.1M. The position accounts for 0.13% of the portfolio, ranked #95.

Walleye Capital first reported a position in PFE in Q3 2019 and has held it in 13 quarters since. The position peaked at $31.9M in Q4 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Walleye Capital held 1,070,486 shares of Pfizer worth $30.1M as of Q1 2026.
  • Walleye Capital bought 596,980 Pfizer shares in Q1 2026, an estimated $15.9M.
  • Pfizer made up 0.13% of Walleye Capital's portfolio in Q1 2026, its #95 holding.
  • Walleye Capital first reported a position in Pfizer in Q3 2019 and has held it in 13 quarters since.
  • Walleye Capital's Pfizer position peaked at $31.9M in Q4 2024.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.